HCPCS Level IIdrugActive
J3392
Inj, exagamglogene autotem
BETOS: O1E
Effective: 2025-01-01
Referenced in 4 policies
Description
Injection, exagamglogene autotemcel, per treatment
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Casgevy
Manufacturer
Vertex Pharmaceuticals, Inc.
HCPCS Dosage
Per Treatment
Billing Units
1.0000
1
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.